ArieL.WeinstockMDFAES (He/Him)

PubMed

• 5 citations
  Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.
  Robert J Flamini, Anne M Comi, E Martina Bebin, Michael G Chez, Gary Clark
  Epilepsia. 2023-08-01
• 38 citations
  Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice.
  Dianalee McKnight, Ana Morales, Kathryn E Hatchell, Sara L Bristow, Joshua L Bonkowsky
  JAMA Neurology. 2022-12-01
• 53 citations
  Long-term safety and efficacy of add-on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long-term open-label extension trial
  Anup D. Patel, Maria Mazurkiewicz-Bełdzińska, Richard F.M. Chin, Antonio Gil-Nagel, Boudewijn Gunning
  Epilepsia. 2021-07-20

Journal Articles

• Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.  
  Devinsky O1, Patel AD1, Cross JH1, Villanueva V1, Wirrell EC1, Privitera M1, Greenwood SM1, Roberts C1, Checketts D1, VanLandingham KE1, Zuberi SM1; GWPCARE3 Study Gro..., N Engl J Med, 5/17/2018
• Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results  
  . Szaflarski JP1, Bebin EM1, Comi AM2, Patel AD3, Joshi C4, Checketts D5, Beal JC6, Laux LC7, De Boer LM8, Wong MH9, Lopez M10, Devinsky O11, Lyons PD12, Zentil PP10, ..., Epilepsia, 7/12/2018
• Pretreatment seizure semiology in childhood absence epilepsy  
  Kessler SK1, Shinnar S2, Cnaan A2, Dlugos D2, Conry J2, Hirtz DG2, Hu F2, Liu C2, Mizrahi EM2, Moshé SL2, Clark P2, Glauser TA2;Abram H, Albers E, Bahna SJ, Ballaban-G..., Neurology, 7/19/2017